Fitness assay and associated methods

Details Fitness assay and associated methods Fitness assay and associated methods

1999-06-23

2008-12-30

Le, Emily M. (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

Reexamination Certificate

active

07470506

ABSTRACT:
The present invention provides an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity relative to its predecessor. The present invention further provides a continuous fluorogenic assay for measuring the anti-HIV protease activity of protease inhibitor. The present invention also provides a method of administering a therapeutic compound that reduces the chances of the emergence of drug resistance in therapy. The present invention also provides a compound of formula (I) or a pharmaceutically acceptable salt, a prodrug, a composition, or an ester thereof, wherein A is a group of formulas (A), (B), (C) or (D); R1, R2, R3, R5or R6is H, or an optionally substituted and/or heteroatom-bearing alkyl, alkenyl, alkynyl, or cyclic group; Y and/or Z are CH2, O, S, SO, SO2, amino, amides, carbamates, ureas, or thiocarbonyl derivatives thereof, optionally substituted with an alkyl, alkenyl, or alkynyl group; n is from 1 to 5; X is a bond, an optionally substituted methylene or ethylene, an amino, O or S; Q is C(O), C(S), or SO2; m is from 0 to 6; R4is OH, ═O (keto), NH2, or alkylamino, including esters, amides, and salts thereof; and W is C(O), C(S), S(O), or SO2. Optionally, R5and R6, together with the N—W bond of formula (I), comprises a macrocyclic ring.

REFERENCES:
patent: 5475027 (1995-12-01), Talley et al.
patent: 5502060 (1996-03-01), Thompson
patent: 5585397 (1996-12-01), Tung et al.
patent: 5691372 (1997-11-01), Tung et al.
patent: 5703076 (1997-12-01), Talley et al.
patent: 5705500 (1998-01-01), Getman et al.
patent: 5723490 (1998-03-01), Tung
patent: 5728718 (1998-03-01), Randad et al.
patent: 5744481 (1998-04-01), Vazquez et al.
patent: 5753660 (1998-05-01), Sikorski et al.
patent: 5766842 (1998-06-01), Heefner et al.
patent: 5843946 (1998-12-01), Vazquez et al.
patent: 6060476 (2000-05-01), Vazquez et al.
patent: 6251874 (2001-06-01), Lisziewicz et al.
patent: 0 337 714 (1989-10-01), None
patent: 0 434 365 (1991-06-01), None
patent: 0 528 661 (1993-02-01), None
patent: 0 534 511 (1993-03-01), None
patent: 0 539 192 (1993-04-01), None
patent: 0 550 924 (1993-07-01), None
patent: 2276621 (1994-10-01), None
patent: WO 90/09191 (1990-08-01), None
patent: WO 90/09191 (1990-08-01), None
patent: WO 94/04492 (1994-03-01), None
patent: WO 94/05639 (1994-03-01), None
patent: WO 9404492 (1994-03-01), None
patent: WO 9405639 (1994-03-01), None
patent: WO 94/14793 (1994-07-01), None
patent: WO 95/06030 (1995-03-01), None
patent: WO 9506030 (1995-03-01), None
patent: WO 96/28463 (1996-09-01), None
patent: WO 9633187 (1996-10-01), None
patent: WO 97/19055 (1997-05-01), None
patent: WO 99/65870 (1999-12-01), None
patent: WO 99/67254 (1999-12-01), None
patent: WO 99/67417 (1999-12-01), None
patent: WO 99/67417 (1999-12-01), None
patent: WO 9967254 (1999-12-01), None
patent: WO 00/48466 (2000-08-01), None
Michael Waldholz, Merck's Elation Over AIDS Drug Sours, Wall Street Journal (Eastern edition). New York, N.Y.: Feb. 25, 1994. p. B5.
Fox, J. No Winner against AIDS. Bio/Technology, vol. 12 (Feb. 1994), p. 128.
Fahey et al. A Status of immune-based therapies in HIV infection and AIDS, Clinical and Experimental Immunology, vol. 88 (1992), pp. 1-5.
Bone et al.,J. Am. Chem. Soc., 113, 9382 (1991).
Borman et al.,J. Gen. Virology, 77(3), 419-426 (Mar. 1996).
Erickson et al.,Science, 249, 527-533 (1990).
Ghosh et al.,Biorganic&Medicinal Chemistry Letters, 8, 687-690 (Mar. 1998).
Ghosh et al.,J. Medicinal Chemistry, 36(16), 2300-2310 (Aug. 1993).
Ghosh et al.,J. Medicinal Chemistry, 36(2), 292-294 (Jan. 1993).
Ghosh et al.,J. Medicinal Chemistry, 37(16), 2506-2508 (Aug. 1994).
Ghosh et al.,J. Medicinal Chemistry, 37, 1177-1188 (Apr. 1994).
Gulnik et al.,Biochemistry, 34(29), 9282-9287 (Jul. 1995).
Ho et al.,J. Virology, 68(3), 2016-2020 (Mar. 1994).
Huff,J. Med. Chem., 34(8), 2305-2314 (Aug. 1991).
Kageyama et al.,Antimicrob Agents Chemother., 36, 926-933 (May 1992).
Kaplan et al.,PNAS USA, 91, 5597-5601 (1994).
Kim et al.,J. Medicinal Chemistry, 38(17), 1181-1182 (1995).
Klabe et al.,Biochemistry, 37(24), 8735-8742 (May 1998).
Kramer et al.,Science, 231, 1580-1584 (1996).
Lyle et al., J. Med. Chem., 34(3), 1228-1230 (Mar. 1991).
Majer et al.,13thAmerican Peptide Symposium, Edmonton, Canada (1993).
Martinez-Picado et al.J. Virology, 73(5), 3744-3752 (May 1999).
McQuade et al.,Science, 247, 454-456 (1990).
Meek et al.,Nature, 343(6253), 90-92 (Jan. 1990).
Meek,J. Enzyme Inhibition, 6(1), 65-98 (Jan. 1992).
Moore et al.,Perspect. Drug Dis. Design, 1, 85-108 (1993).
Norbeck et al.,Ann. Reports Med. Chem., 26, 141-150 (1991).
Otto et al.,PNAS USA, 90, 7543-7547 (1993).
Plattner et al.,Drug Discovery Technologies, Clark et al., eds., Ellish Horwood, Chichester, England, 92-126 (1990).
Rich et al.,J. Med. Chem., 33(5), 1285-1288 (May 1990).
Roberts et al.,Science, 248, 358-361 (1990).
Tomasselli et al.,Int. J. Chem. Biotechnology, 6, 6-27 (1991).
Vacca et al.,J. Med. Chem., 34(3), 1225-1228 (Mar. 1991).
Vazquez et al.,J. Medicinal Chemistry, 38(4), 581-584 (Feb. 1995).
Chakraborty et al.,Tetrahedron Letters, 41, 10121-10125 (2000).
Ghosh et al.,Drug Design and Discovery, 10, 77-88 (1993).
Ghosh et al.,J. Med. Chem., 36, 924-927 (1993).
Ghosh et al., 207thAmerican Chem. Soc. Nat'l Meeting, Medi 37 (Mar. 13-17, 1994).
Ghosh et al., 210thAmerican Chem. Soc. Nat'l Meeting, Medi 27 (Aug. 20-24, 1995).
Ghosh et al.,Bioorganic&Med. Chem. Lett., 5(1), 83-88 (1995).
Ghosh et al.,Tetrahedron Letters, 36 (4), 505-508 (1995).
Ghosh et al.,J. Med. Chem., 39, 3278-3290 (1996).
Ghosh et al., 216thAmerican Chem. Soc. Nat'l Meeting, Medi 229 (1998).
Ghosh et al.,Bioorganic&Med. Chem. Lett., 8, 979-982 (1998).
Ghosh et al.,Tetrahedron Letters, 39, 4651-4654 (1998).
Ghosh et al., 39thInterscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Calif., Session 89F, paper 928, (Sep. 26-29, 1999).
Ghosh et al.;Antiviral Research, 51, p. 26, Abstract 035 (2001).
Ghosh et al.,Il Farmaco, 56, 29-32 (2001).
Ghosh et al.,J. Med. Chem., 44, 2865-2868 (2001).
Holloway et al.,J. Med. Chem., 38, 305-317 (1995).
Hong et al.,Science, 290 (5489), 150-153, (Oct. 6, 2000).
Huff et al.,Journal of Cellular Biochemistry., p. 130, S 037 (Feb. 26-Apr. 17, 1994).
Koh et al.,Antimicrob. Agents Chemother., 47, 3123-3129 (2003).
Ray et al.,Apoptosis, 5, 509-514 (2000).
Turner et al.,Biochemistry, 40 (34), 10001-10006 (Aug. 28, 2001).
Upadhyaya et al.,Arch. Virol., 140, 1945-1956 (1995).
Walia et al.,Infection and Immunity, 67, 5215-5222 (Oct. 1999).
Yoshimura et al.,J. Virol., 1349-1358 (Feb. 2002).
U.S. Appl. No. 11/030,632, Utility Patent Application Transmittal with Fee Transmittal, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Application Data Sheet, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Certificate of Express Mailing, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Preliminary Amendment signed Jan. 5, 2005, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Specification, Claims, and Abstract, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Drawings, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Combined Declaration and Power of Attorney signed by John W. Erickson, Sergei V. Gulnik, and Hiroaki Mitsuya, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Statement Under 37 C.F.R. 1.48(a)(2), filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Combined Declaration and Power of Attorney signed by Applicant Arun K. Ghosh, filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Request for Correction of Inventorship of Patent Application Under 37 C.F.R. 1.48(a), filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Written Consent of Assignee (the Government of the United States . . . ) Under 37 C.F.R. 1.48(a)(5), filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Written Consent of Assignee (Board of Trustees of the University of Illinois) Under 37 C.F.R. 1.48(a)(5), filed Jan. 6, 2005.
U.S. Appl. No. 11/030,632, Assignment from Aurn K. Ghosh to the Board of Trustees of the University of Illinois, filed Jan. 6, 2005.

Affiliated with

Also associated with

Rating

Fitness assay and associated methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fitness assay and associated methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fitness assay and associated methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4047541